Skip to main content
Springer Nature Link
Log in

Anti-Saccharomyces cerevisiae Antibody Does Not Differentiate Between Crohn's Disease and Intestinal Tuberculosis

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The clinical, morphological, and histological features of intestinal tuberculosis (IT) and Crohn's disease (CD) mimic so much, that it becomes difficult to differentiate between them. The sensitivity of anti-Saccharomyces cerevisiae antibody (ASCA) IgG and ASCA IgA in CD is 60%–80%, whereas the specificity is almost 90%. There are no reports of study of ASCA in patients with IT, nor has it ever been used to differentiate CD from IT. Patients with ulcerative colitis (UC; n=25), CD (n=59), and IT (n=30) and 21 healthy controls were included in this study. The location and behavior of CD were classified according to the Modified Montreal classification. Five milliliters of blood was taken from them and serum was stored at −70°C. ASCA antibodies (both IgG and IgA) were estimated using commercially available ELISA kits (AESKU Diagnostics, Germany). Anti-neutrophilic cytoplasmic antibody was measured by indirect immunoflorescence test. ASCA IgA was positive in 4.7%, 28%, 33.9%, and 43.3% and ASCA IgG was positive in 4.7%, 24%, 50.8%, and 46.6% of healthy controls and patients with UC, CD, and IT, respectively. Either ASCA IgG or ASCA IgA was positive in 9.5%, 40%, 61% and 66.6% of healthy controls, UC, CD, and IT, respectively. ANCA was positive in 0%, 32%, 10.1%, and 6.6% of healthy controls, UC, CD, and IT, respectively. ASCA IgG was positive in a significantly higher number of patients with CD (P<0.0001) and IT (P<0.0001) in comparison to healthy controls. ASCA IgA was positive in a significantly higher number of patients with UC (P<0.04), CD (P<0.013), and IT (P<0.006) in comparison to healthy controls. In comparisons between diseases, ASCA IgG was positive in significantly more patients with CD (P<0.001) and IT (P<0.001) in comparison to UC. There was no significant difference in ASCA IgA (33.9% vs. 43.3%), ASCA IgG (50.86% vs. 46.6%), or ANCA (10.7%, 7.4%) in patients with CD and IT, respectively. There was no correlation between ASCA and duration, location and behavior of CD, and IT. We conclude that ASCA IgG and ASCA IgA do not help to differentiate between IT and CD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Anand BS (1989) Distinguishing Crohn's disease from intestinal tuberculosis. Natl Med J India 2:170–175

    Google Scholar 

  2. Kaushik SP, Bassett ML, McDonald C, Lin BP, Bokey EL (1996) Case report: gastrointestinal tuberculosis simulating Crohn's disease. J Gastroenterol Hepatol 11:532–534

    PubMed  CAS  Google Scholar 

  3. Jayanthi V, Robinson RJ, Malathi S, Rani B, Balambal R, Chari S, Taghuram K,Madanagopalan N, Mayberry JF (1996) Does Crohn's disease need differentiation from tuberculosis? J Gastroenterol Hepatol 11:183–186

    PubMed  CAS  Google Scholar 

  4. Arnold C, Moradpour D, Blum HE (1998) Tuberculous colitis mimicking Crohn's disease. Am J Gastroenterol 93:2294–2296

    Article  PubMed  CAS  Google Scholar 

  5. Shah S, Thomas V, Mathan M, Chacko A, Chandy G, Ramakrishna BS, Rolston DD (1992) Colonoscopic study of 50 patients with colonic tuberculosis. Gut 33:347–351

    Article  PubMed  CAS  Google Scholar 

  6. Patel N, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, Gupte P (2004) Gastrointestinal luminal tuberculosis: establishing the diagnosis. J Gastroenterol Hepatol 19:1240–1246

    Article  PubMed  Google Scholar 

  7. Pai CG, Khandge GK (2000) Is Crohn's disease rare in India? Indian J Gastroenterol 19:17–20

    PubMed  CAS  Google Scholar 

  8. Yang SK, Loftus EV Jr, Sandborn WJ (2001) Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 7:260–270

    Article  PubMed  CAS  Google Scholar 

  9. Ouyang Q, Tandon R, Goh KL, Ooi CJ, Ogata H, Fiocchi C (2005) The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol 21:408–413

    PubMed  Google Scholar 

  10. Makharia GK (2006) Rising incidence and prevalence of Crohn's disease in Asia: Is it apparent or real? J Gastroenterol Hepatol 21:929–931

    Article  PubMed  Google Scholar 

  11. APDW 2004 Chinese IBD Working Group (2006) Retrospective analysis of 515 cases of Crohn's disease hospitalization in China: nationwide study from 1990 to 2003. J Gastroenterol Hepatol 21:1009–1015

    Article  Google Scholar 

  12. Zhou ZY, Luo HS (2006) Differential diagnosis between Crohn's disease and intestinal tuberculosis in China. Int J Clin Pract 60:212–214

    Article  PubMed  CAS  Google Scholar 

  13. Makharia GK, Banerjee D, Datta Gupta S, Tandon RK (2004) Differentiation of Crohn's disease from intestinal tuberculosis in India. Indian J Gastroenterol 23(Suppl):A40

    Google Scholar 

  14. Lee YJ, Yang SK, Byeon JS, Myung SJ, Chang HS, Hong SS, Kim KJ, Lee GH, Jung HY, Hong WS, Kim JH, Min YI, Chang SJ, Yu CS (2006) Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease. Endoscopy 38:592–597

    Article  PubMed  CAS  Google Scholar 

  15. Tandon HD, Prakash A (1972) Pathology of intestinal tuberculosis and its distinction from Crohn's disease. Gut 13:260–269

    Article  PubMed  CAS  Google Scholar 

  16. Pulimood AB, Peter S, Ramakrishna B, Chacko A, Jeyamani R, Jeyaseelan L, Kurian G (2005) Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn's disease. J Gastroenterol Hepatol 20:688–696

    Article  PubMed  Google Scholar 

  17. Gan HT, Chen YQ, Ouyang Q, Bu H, Yang XY (2002) Differentiation between intestinal tuberculosis and Crohn's disease in endoscopic biopsy specimens by polymerase chain reaction. Am J Gastroenterol 97:1446–1451

    Article  PubMed  Google Scholar 

  18. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus Jr EV, Pena AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5–36

    PubMed  Google Scholar 

  19. Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749–753

    Article  PubMed  CAS  Google Scholar 

  20. Sandborn WJ (2004) Serologic markers in inflammatory bowel disease: state of the art. Rev Gastroenterol Disord 4:167–174

    PubMed  Google Scholar 

  21. Sostegni R, Daperno M, Ercole E, Rigazio C, Bresso F, Masoero G, Castellino F, Zaffino C, Rocca R, Molinaro GC, Rocca G, Astegiano M, Pera A (2001) Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it a reliable diagnostic and prognostic marker? Dig Liver Dis 33:755–761

    Article  PubMed  CAS  Google Scholar 

  22. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D (1998) Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42:788–791

    Article  PubMed  CAS  Google Scholar 

  23. Rutgeerts P, Vermeire S (1998) Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. Gastroenterology 115:1006–1009

    Article  PubMed  CAS  Google Scholar 

  24. Savige JA, Paspaliaris B, Silvestrini R, Davies D, Nikoloutsopoulos T, Sturgess A, Neil J, Pollock W, Dunster K, Hendle M (1998) A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. J Clin Pathol 51:568–575

    Article  PubMed  CAS  Google Scholar 

  25. Barnes RM, Allan S, Taylor-Robinson CH, Finn R, Johnson PM (1990) Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: Is IgA antibody a marker for Crohn's disease? Int Arch Allergy Appl Immunol 92:9–15

    PubMed  CAS  Google Scholar 

  26. Floch MH (2003) Saccharomyces: Is it a probiotic or a pathogen and what is the significance of an elevated anti-S. cerevisiae antibody? J Clin Gastroenterol 36:5–6

    Article  PubMed  Google Scholar 

  27. Barta Z, Csipo I, Szabo GG, Szegedi G (2003) Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. World J Gastroenterol 9:2308–2312

    PubMed  Google Scholar 

  28. Breslin NP, Nash C, Hilsden RJ, Hershfield NB, Price LM, Meddings JB, Sutherland LR (2001) Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Am J Gastroenterol 96:2934–2938

    Article  PubMed  CAS  Google Scholar 

  29. Hollander D (2002) Crohn's disease, TNF-alpha, and the leaky gut. The chicken or the egg? Am J Gastroenterol 97:1867–1868

    PubMed  Google Scholar 

  30. Irvine EJ, Marshall JK (2000) Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 119:1740–1744

    Article  PubMed  CAS  Google Scholar 

  31. Harrer M, Reinisch W, Dejaco C, Kratzer V, Gmeiner M, Miehsler W, Norman GL, Gangl A, Vogelsang H (2003) Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur J Gastroenterol Hepatol 15:1281–1285

    Article  PubMed  CAS  Google Scholar 

  32. Vermeire S, Peeters M, Vlietinck R, Joossens S, Den Hond E, Bulteel V, Bossuyt X, Geypens B, Rutgeerts P (2001) Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 7:8–15

    Article  PubMed  CAS  Google Scholar 

  33. Sendid B, Colombel JF, Jacquinot PM, Faille C, Fruit J, Cortot A, Lucidarme D, Camus D, Poulain D (1996) Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 3:219–226

    PubMed  CAS  Google Scholar 

  34. Seibold F, Konrad A, Flogerzi B, Seibold-Schmid B, Arni S, Juliger S, Kun JF (2004) Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease. Gastroenterology 127:1076–1084

    Article  PubMed  CAS  Google Scholar 

  35. Mallant-Hent RCh, Mary B, von Blomberg E, Yuksel Z, Wahab PJ, Gundy C, Meyer GA, Mulder CJ (2006) Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Eur J Gastroenterol Hepatol 18:75–78

    Article  PubMed  CAS  Google Scholar 

  36. Condino AA, Hoffenberg EJ, Accurso F, Penvari C, Anthony M, Gralla J, O'Connor JA (2005) Frequency of ASCA seropositivity in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 41:23–26

    Article  PubMed  CAS  Google Scholar 

  37. Hoffman IE, Demetter P, Peeters M, De Vos M, Mielants H, Veys EM, De Keyser F (2003) Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis 62:455–459

    Article  PubMed  CAS  Google Scholar 

  38. Wallaert B, Colombel JF, Adenis A, Marchandise X, Hallgren R, Janin A, Tonnel AB (1992) Increased intestinal permeability in active pulmonary sarcoidosis. Am Rev Respir Dis 145:1440–1445

    PubMed  CAS  Google Scholar 

  39. Greenstein RJ (2003) Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 3:507–514

    Article  PubMed  Google Scholar 

  40. Naser SA, Ghobrial G, Romero C, Valentine JF (2004) Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364:1039–1044

    Article  PubMed  Google Scholar 

  41. Flores-Suarez LF, Cabiedes J, Villa AR, Van Der Woude FJ, Alcocer-Varela J (2003) Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis. Rheumatology (Oxford) 42:223–229

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This project was funded by the Research Committee of All India Institute of Medical Sciences, New Delhi. This paper was presented at the 151st Falk Symposium on Emerging Issues in Inflammatory Bowel Diseases, held in Sydney, March 24–25, 2006, and received First Prize.

Author information

Authors and Affiliations

  1. Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India

    Govind K. Makharia, Vikas Sachdev & Suman Lal

  2. Department of Medicine, All India Institute of Medical Sciences, New Delhi, India

    Rajiva Gupta

  3. Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India

    R. M. Pandey

Authors
  1. Govind K. Makharia
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Vikas Sachdev
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Rajiva Gupta
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Suman Lal
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. R. M. Pandey
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Govind K. Makharia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Makharia, G.K., Sachdev, V., Gupta, R. et al. Anti-Saccharomyces cerevisiae Antibody Does Not Differentiate Between Crohn's Disease and Intestinal Tuberculosis. Dig Dis Sci 52, 33–39 (2007). https://doi.org/10.1007/s10620-006-9527-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9527-0

Keywords